跳至主要内容
临床试验/NCT01152502
NCT01152502已完成不适用

Paracetamol Metabolism in Post Operative Conditions

University Hospital, Clermont-Ferrand1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2008年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
Follow-up of urinary concentration from paracetamol metabolites by patients with aortic surgery during 4 days therapeutic intake (perfalgan ® 4 x 1g IV/day)

研究概览

简要总结

Follow-up of urinary concentration from paracetamol metabolites by patients with aortic surgery during 4 days therapeutic intake (perfalgan ® 4 x 1g IV/day)

详细描述

D-15 to D0: selection

  • patient information and non-opposition obtained
  • inclusion and non inclusion criteria check
  • clinical exam

D-1 to D0 : 24 hours diuresis

D0 : operation day

Before anesthesia :

研究设计

研究类型
Observational
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • aortic surgery
  • treatment with intraveinous paracetamol (4 grammes daily during 4 days)
  • patient agrees to participate

排除标准

  • - patient disagrees
  • paracetamol contra-indication
  • paracetamol intake 5 days before surgery

结局指标

主要结局

Follow-up of urinary concentration from paracetamol metabolites by patients with aortic surgery during 4 days therapeutic intake (perfalgan ® 4 x 1g IV/day)

时间窗: during 4 days therapeutic intake

次要结局

  • - Follow-up of glutathion concentration during 4 post operative days(during 4 post operative days)
  • Monitoring of liver function

研究者

发起方
University Hospital, Clermont-Ferrand
申办方类型
Other

研究点 (1)

Loading locations...

相似试验